Tested Applications
| Positive WB detected in | human liver tissue |
| Positive IHC detected in | human liver cancer tissue, human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12365-1-AP targets Cytochrome b5 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3038 Product name: Recombinant human Cytochrome b5 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-108 aa of BC015182 Sequence: MAEQSDEAVKYYTLEEIQKHNHSKSTWLILHHKVYDLTKFLEEHPGGEEVLREQAGGDATENFEDVGHSTDAREMSKTFIIGELHPDDRPKLNKPPETLITTIDSSSS Predict reactive species |
| Full Name | cytochrome b5 type A (microsomal) |
| Calculated Molecular Weight | 134 aa, 15 kDa |
| Observed Molecular Weight | 15 kDa |
| GenBank Accession Number | BC015182 |
| Gene Symbol | Cytochrome b5 |
| Gene ID (NCBI) | 1528 |
| RRID | AB_2089808 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P00167 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for Cytochrome b5 antibody 12365-1-AP | Download protocol |
| WB protocol for Cytochrome b5 antibody 12365-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Cytochrome b5 Polyclonal antibody (Cat# 12365-1-AP) has 3 citations. They appear in Proteomics Clin Appl, International Journal of Women's Health, and Human Mutation. Research fields span quantitative proteomics of ureteropelvic junction obstruction, breast cancer prognostic stratification and cancer stem cell metabolism, and xenobiotic metabolism gene analysis in liver cirrhosis-to-hepatocellular carcinoma progression. Two studies used the antibody for Western blot in human samples.
| Species | Application | Title |
|---|---|---|
Proteomics Clin Appl Quantitative Proteome of Infant Stenotic Ureters Reveals Extracellular Matrix Organization and Oxidative Stress Dysregulation Underlying Ureteropelvic Junction Obstruction. | ||
Int J Womens Health Novel Perspective for Prognostic Stratification and Personalized Therapy in Breast Cancer Patients: Development of Cancer Stem Cells and Metabolism-Associated Prognostic Model. | ||
Hum Mutat Integrated Bulk and Single-Cell Transcriptomic Analysis Reveals Xenobiotic Metabolism Genes Drive Progression From Liver Cirrhosis to Hepatocellular Carcinoma. |











